The BIOprinting is a novel technique that has revolutionized the world of regenerative medicine and tissue engineering in recent years. This technique makes it possible to manufacture three-dimensional structures of living tissue using a specialized 3D printer that allows the addition of cells and biocompatible materials. BIOprinting has been researched and used in a wide range of applications.
One of the leading research centers in the field of BIOprinting is TECHNALIAa benchmark entity in applied research and technological development at an international level, member of the Basque Research and Technology Alliance. This research center has recently incorporated the 3D BIOprinter DomeBIO 4Aexclusively distributed by IT3D Group.
Integration of DomoBIO 4A in TECNALIA projects
Founded in 2001, TECNALIA is one of the largest applied research centers in the world. Its success in developing innovative and sustainable solutions to today’s technological challenges positions it as a unique center of its kind. Added to this is his constant commitment to research and development projects both nationally and internationally.
Its constant commitment to innovation, together with the need to incorporate state-of-the-art machinery in the field of BIOprinting, have led TECNALIA to integrate DomoBIO technology into its work team.
The DomoBIO 4A developed by DomoTek and exclusively distributed by IT3D Group, combines the necessary technologies to carry out your research. With its four advanced heads (extrusion, UV, FDM and electrospinning) and its heated platform, TECNALIA tackles projects that range from tissue engineering to drug evaluation.
Field of work and line of research in which the DomoBIO equipment is used
The DomoBIO 4A enhances the manufacture of custom implantsthe tissue engineeringthe regenerative medicine and the implementation of advanced therapies. The DomoBIO 3D printer has also been used in the manufacture of in vitro 3D models for the drug evaluation and for the study of his Cellular and molecular biology.
One of the most recent projects published by TECNALIA focused its activity on engineering the microenvironment of wounds through advanced BIOprinting of dressings. This study, published in the International Journal of Molecular Sciences, presented a BIOprinting strategy to create three-dimensional dressings that could help promote chronic wound healing. The TECNALIA research team used the DomoBIO 4A printer to print the dressings using biocompatible materials and skin cells.
The TECNALIA research team has also made significant advances in the BIOprinting of tissues and organs. Another of his projects in which DomoBIO has played a fundamental role has been the creation of 3D models of the nervous system using a matrix of decellularized porcine adipocytes. This work demonstrated the potential of 3D biotechnology in the field of creating highly structured and complex tissue models.
Other applications of BIOprinting
In addition to the aforementioned projects linked to TECNALIA, BIOprinting offers unique solutions in different environments linked to medicine. The 3D manufacturing of personalized implants, the creation of advanced tissues, or the generation of functional organs for transplants…
BIOprinting has also shown great potential in the production of in vitro 3D models for drug evaluation. By producing artificial tissues and organs, the effects of different drugs can be evaluated under controlled conditions. This solution can lead to the development of more effective and personalized treatments.
Definitely, TECNALIA has found in the DomoBIO 4A the solution to grow in the field of BIOprinting and the handling of advanced materials. IT3D Group is proud that an entity of international relevance such as TECNALIA trusts in its technology to increase its performance. If you are interested in learning more about our BIOprinting, nanotechnology and advanced materials handling solutions, visit our website.
www.it3d.com
Leave a Reply